Bangladesh gets a head start over India in export of weight-loss drugs to emerging markets
As Indian drug giants rush to export weight-loss drug semaglutide in countries that don’t have patent exclusivity, they face an unlikely adversary in their neighbour.
As Indian drug giants rush to export weight-loss drug semaglutide in countries that don’t have patent exclusivity, they face an unlikely adversary in their neighbour.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
